Mrs. Janene E. Rodriguez, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 336 Prospect Ave, Hackensack, NJ 07601 Phone: 201-518-7712 |
Ms. Katherine Malmrose, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 160 Overlook Ave, Hackensack, NJ 07601 Phone: 201-230-5607 |
Katherine A Malmrose Ms Ccc-slp Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 160 Overlook Ave Ste 1a, Hackensack, NJ 07601 Phone: 201-230-5607 |
Sarah Poplawski, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 90 Prospect Ave Apt 6e, Hackensack, NJ 07601 Phone: 973-941-5546 |
Miss Joy Jable, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Colonial Ter, Hackensack, NJ 07601 Phone: 201-996-9264 |
Susan Rothschild, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 381 Park St Ste 1a, Hackensack, NJ 07601 Phone: 201-880-6009 |
Ambily Varughese, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Colonial Ter, Hackensack, NJ 07601 Phone: 201-753-3638 |
News Archive
MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA) today announced that on 22 June the European Commission approved SIMPONI (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA).
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a research collaboration with Professor Marianne van Hage, research group leader and Head of the Clinical Immunology and Allergy Unit and Vice Head of the Department of Medicine at Karolinska Institutet in Stockholm, Sweden.
Continuing a proud tradition, BioTek Instruments will receive the 2015 Governor's Excellence in Worksite Wellness Award, presented by the Governor's Council on Physical Fitness and Sports.
The Portage Health Board of Directors has signed a definitive agreement to form a joint venture with LifePoint Hospitals. The agreement, which includes $60 million in capital investments over the next 10 years by the new joint venture, would allow Portage Health to expand and enhance its services to better meet the healthcare needs of its communities.
› Verified 2 days ago